Stocks and Investing Stocks and Investing
Mon, September 23, 2024

Leland Gershell Reiterated (CAPR) at Buy and Held Target at $15 on, Sep 23rd, 2024


Published on 2024-10-28 14:23:59 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Reiterated "Capricor Therapeutics, Inc." (CAPR) at Buy and Held Target at $15 on, Sep 23rd, 2024.

Leland has made no other calls on CAPR in the last 4 months.



There are 3 other peers that have a rating on CAPR. Out of the 3 peers that are also analyzing CAPR, 0 agree with Leland's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Leland


  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $8 on, Friday, September 20th, 2024
  • Jason McCarthy of "Maxim Group" Reiterated at Strong Buy and Held Target at $12 on, Tuesday, September 17th, 2024
  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Tuesday, September 17th, 2024
Contributing Sources